The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2 — John Shaqi
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
“Large doses must be given if we expect to control the convulsions.
We are to be guided by the frequency and the severity of the
seizures, the saturation of the system by bromides and by the age
of the patient. The rule is ‘large doses for long periods but with
occasional periodic monthly or quarterly omissions.’ When we have
succeeded in controlling the convulsions in so far as greatly
diminishing the frequency and severity of the attacks we may then
attempt to decrease the dose, but the results must be carefully
watched. Increase in frequency of convulsive seizures is a sign
that the bromides must again be pushed as before.”
The best modern clinical teaching concerning the treatment of epilepsy
is that bromids should be avoided except as a last resort. Bromids
do not cure, and the amount necessary to control the convulsions may
produce a degree of mental hebetude that is a greater evil than the
disease itself.
It is recommended that the preparation be held ineligible for admission
to N. N. R., because of its conflict with Rules 1, 4, 6 and 10 of the
Council, and that this report be published.
CHIONIA
Chionia, according to the statement of the Peacock Chemical Company,
which exploits the product, contains 19 per cent. alcohol and is “A
Preparation of Chionanthus Virginica.”[4]
[4] Of Chionanthus Virginica or fringe-tree, the Council on Pharmacy
and Chemistry in its 1912 report on “Some Unimportant Drugs” said:
“The drug is much used by eclectics and homeopathists, especially as
a depurant in hepatic and syphilitic disorders.... The claims for
this remedy are not supported by experimental evidence and clinical
reports of its use fail to show indications of discriminating critical
observation. It is not noticed by most pharmacologic authorities.”
This preparation is advertised particularly as “a potent hepatic
stimulant” and special claims are made for it in various disturbances
of the liver:
“Chionia is very well adapted in the treatment of hepatic
congestion owing to its specific action in depleting the portal
circulation.”
In passive congestion of the liver, the manufacturers would have us
believe
“... we have a drug in Chionia that will stimulate the circulation
of the blood and lymphatics of the liver as well as stimulate its
physiological activities and instead of the patient vomiting the
blood an internal depletion of the liver occurs.”
“... in cases of simple jaundice due to circulatory (congestive)
changes in the liver, Chionia is the drug ‘par excellence’ that
will rapidly cause a disappearance of this symptom.”
As a prophylactic against eclampsia, if a history of torpidity of the
liver is obtained:
“CHIONIA should be used during the major portion of child-bearing
period because it acts directly on the liver stimulating its
functional activity.”
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account